Intricate Proteoform Heterogeneity in the Tailpiece of IgA within and across Its Circulatory and Secretory Configurations
Weiwei Wang, Amber D. Rolland, Gestur Vidarsson, Johannes B. van Goudoever, Karli R. Reiding, Albert Bondt, Albert J. R. HeckAbstract
Human immunoglobulin A (IgA) naturally occurs in multiple molecular forms─monomers, dimers, and even higher-order polymers─that are differentially distributed across serum, breast milk, and mucosal surfaces. The C-terminal tailpiece of IgA is essential to its polymerization mediated by the joining chain (J-chain) and thus also an important determinant of its extensive structural heterogeneity, yet its features remain somewhat poorly defined. Here, we used HILIC-LC-MS/MS-based glycopeptide analysis to characterize the N-glycan structures, disulfide linkages, and C-terminal amino acid sequence variants within the IgA tailpiece across the different molecular configurations of endogenous IgA. We find extensive correlation between these post-translational modifications; i.e., variations in tailpiece Asn459 N-glycosylation, redox status and disulfide connectivity of Cys471, and the presence or absence of C-terminal Tyr472 are intrinsically interconnected. When Cys471 was disulfide-bound to the J-chain, Asn459 glycans showed broader structural heterogeneity and retained more high-mannose structures, whereas free Cys471 tailpieces mainly carried mature, sialylated complex-type glycans. Serum IgA and milk SIgA displayed distinct tailpiece signatures, including differences in N-glycan maturation and processing of the ultimate C-terminal Tyr472 residue. Together, these findings define biofluid-specific molecular forms of IgA and highlight the remarkable structural diversity of the human IgA tailpiece. Overall, our results advance the understanding of the IgA structure and could offer a much-needed molecular basis to assist future bioengineering of IgA-based therapeutics.